Skip to content

About
Platform
Pipeline
News
Careers
Contact Us

About
Platform
Pipeline
News
Careers
Contact Us

Latest News and Insights

All

Press Releases

D2M Biotherapeutics Announces First Patient Dosed in A Phase 1 Study Evaluating DM919, a Novel MICA/B Antibody for Treating Patients with Advanced Solid Tumors

Natick, Mass., April 19, 2024 -- D2M Biotherapeutics, Inc. (D2M),...

High-tech Immunotherapeutics

Press Releases

D2M Biotherapeutics DM919 Investigational New Drug Application Approved by China’s National Medical Products Administration

Natick, Mass., April 1st, 2024 -- D2M Biotherapeutics Inc (D2M),...

Genetic Sequence Pipette

Press Releases

DM919 Receives FDA Clearance of IND Application to Treat Solid Tumors

D2M Biotherapeutics Announces FDA Clearance of Investigational New Drug (IND)Application...

Want to Work With Us?

Contact Us for Partnership Inquiries

Let’s Make Medicine

© 2024 D2M Biotherapeutics | Privacy Policy

About
- Our Team
- Partnerships
Platform
Pipeline
News
Careers
Contact